Skip to main content
TipRanks
Go Ultimate75% OFF

Karyopharm Therapeutics (25K0) Q2 2024 Earnings Report

1 Followers

DE:25K0 Q2 2024 EPS Results

Actual EPS
-EUR 2.69
Consensus EPS
-EUR 4.01
Beat/Miss
Beat by +EUR 1.32
One Year Ago EPS
-EUR 3.90

DE:25K0 Q2 2024 Revenue Results

Actual Revenue
EUR 38.37M
Expected Revenue
EUR 32.47M
Beat/Miss
Beat by +EUR 5.90M
YoY Revenue Growth
+13.86%

Earnings Announcement Details

Quarter
Q2 2024
Date
08/06/2024
Time
Before Open
Conference Call
Tuesday, August 6, 2024
DE:25K0 Upcoming Earnings

Karyopharm Therapeutics's next earnings date is estimated for February 10, 2027, based on past reporting schedules.

Q2 2024 Earnings Call Audio

DE:25K0 Q2 2024 Earnings Call
0:00 / 0:00

Q2 2024 Earnings Slide Deck

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:25K0 Earnings History

DE:25K0 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 10, 20272026 (Q4)―--5.12――
Oct 29, 20262026 (Q3)-0.30--3.43―
Aug 13, 20262026 (Q2)-1.23-2.08-3.8746.30% (+1.79)
May 14, 20262026 (Q1)-1.27-1.11-2.4855.23% (+1.37)
Feb 12, 20262025 (Q4)-1.79-5.12-3.23-58.61% (-1.89)
Nov 03, 20252025 (Q3)-3.11-3.43-3.52.05% (+0.07)
Aug 11, 20252025 (Q2)-3.66-3.87-2.69-44.00% (-1.18)
May 12, 20252025 (Q1)-3.96-2.48-4.342.29% (+1.82)
Feb 19, 20252024 (Q4)-3.52-3.23-4.8433.33% (+1.61)
Nov 05, 20242024 (Q3)-3.54-3.50-4.0413.33% (+0.54)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed